Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®

Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of similarity starts with the comprehensive analysis of the reference product and its proposed biosimilar at the physicochemical and functional levels. Here, we report the r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:MAbs
Egile Nagusiak: Magnenat, Laurent, Palmese, Angelo, Fremaux, Christèle, D'Amici, Fabio, Terlizzese, Mariagrazia, Rossi, Mara, Chevalet, Laurent
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2016
Gaiak:
Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240642/
https://ncbi.nlm.nih.gov/pubmed/27854156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1259046
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak